Valuation Supernus Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-06-12 EDT			5-day change	1st Jan Change
44.41 ^USD	-2.50%		-0.76%	-10.64%

05-13	Supernus Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:40 PM
05-05	Supernus Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 05, 2026

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,551	1,928	1,581	1,997	2,850	2,578	-	-
Change	-	24.34%	-18%	26.29%	42.72%	-9.55%	-	-
Enterprise Value (EV)	1,551	1,928	1,581	1,997	2,850	2,578	2,578	2,578
Change	-	24.34%	-18%	26.29%	42.72%	-9.55%	0%	0%
P/E Ratio	29.8x	34.3x	1,447x	27.4x	-73.1x	102x	31.3x	17.9x
PBR	-	-	-	-	-	-	-	-
PEG	-	5.6x	-14.8x	0x	0x	-1x	0x	0.2x
Capitalization / Revenue	2.67x	2.89x	2.6x	3.02x	3.96x	2.97x	2.53x	2.2x
EV / Revenue	0x	0x	0x	0x	0x	2.97x	2.53x	2.2x
EV / EBITDA	0x	0x	0x	0x	0x	16.4x	9.29x	6.46x
EV / EBIT	0x	0x	0x	0x	0x	17.3x	9.4x	6.64x
EV / FCF	0x	0x	0x	0x	0x	21.7x	11.6x	7.52x
FCF Yield	8.07%	6.04%	6.99%	8.58%	1.61%	4.6%	8.64%	13.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.98	1.04	0.02	1.32	-0.68	0.4333	1.42	2.485
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	579.8	667.2	607.5	661.8	719	867.3	1,020	1,169
EBITDA ¹	118.6	128.8	97.3	159.6	250.3	157.2	277.4	399
EBIT ¹	86.03	46.12	125.1	183.7	158.7	149.4	274.2	388.5
Net income ¹	53.42	60.71	1.316	73.86	-38.55	25.2	82.76	143.6
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	29.16	35.67	28.94	36.16	49.70	44.41	44.41	44.41
Nbr of stocks (in thousands)	53,181	54,058	54,633	55,219	57,339	58,040	-	-
Announcement Date	4/13/22	2/28/23	2/27/24	2/25/25	2/24/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUPERNUS PHARMACEUTICALS, INC.	102.49x	-	-	-.--%	2.58B
MERCK & CO., INC.	53.11x	4.94x	20.09x	2.81%	294B
MERCK KGAA	22.51x	3.11x	11.05x	1.75%	67.08B
HALOZYME THERAPEUTICS, INC.	10.32x	5.32x	8.2x	-	8.24B
KYOWA KIRIN CO., LTD.	15.56x	1.94x	6.68x	2.87%	7.84B
SK BIOPHARMACEUTICALS CO., LTD.	22.12x	6.62x	18.11x	-.--%	4.54B
YUHAN CORPORATION	42.86x	2.43x	29.57x	0.72%	3.8B
BETTA PHARMACEUTICALS CO., LTD.	28.8x	5.51x	15.75x	-	3.35B
Average	37.22x	4.27x	15.63x	1.36%	48.93B
Weighted average by Cap.	45.87x	4.57x	18.04x	2.55%